chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 01-FEB-2016, the patient was inadvertently administered with both VARIVAX (Merck) (lot # L013827 with expiration date 21-APR-2017, dose and route unspecified) and PROQUAD (Merck) (Lot # L030587 with expiration date 10-FEB-2017, dose and route unspecified) (overdose). No adverse effect was reported. Additional information has been requested.
pt recv vax & pt exp breakthrough chickenpox consisting of 30 vesicles scattered over the entire body;
Temp. of 104 F, Left upper arm infection as stated by mom 24 hours post vaccination.
Awoke 3rd day after vaccination with severe positional vertigo or similar disorder - felt when I simply turned my head on pillow.  It was as if I was falling in space, especially my head. Could  not sit up without feeling terrible. Lessened somewhat during day but could not move head without feeling vertigo/dizziness.  Unable to eat without nausea and vomiting.  That was 04/09/21. On 04/10 and 04/11 it was difficult to arise from bed without feeling very dizzy. But after getting up very slowly without moving head, I could move slowly to use  bathroom, get a little food, etc.  Today, 04/12, still had to arise from bed very slowly, trying not to move head to avoid weird dizzy type feeling.  Have been able to eat, get dressed and leave the house carefully. Try not to move head too much and move rather slowly.
Circular red, itchy rash at shot site on left upper arm.   About 2 inches across -- slightly raised and very itchy at first.    First noticed it  9 days after vaccination, very early am.   Annoying but responds to cortisone cream.
IM given 12/18/2020 at 2:40 pm , evening time 9pm claimed fever(no temperature was taken) ;; chills, myalgia, headache on and off tolerable on and off; nauseated (common symptom even in situations employee does not feel well); Took Motrin alternating with Acetaminophen at least 2 tabs a day of each. Medications alleviate symptoms but recurs again until after 48 hours Showed at work but decided to leave work to return to residence. Advised to contact primary care provider to inform provider of the signs and symptoms. Employee was advised to get Covid TEST (PCR)
5 minutes post vaccine -> felt dizzy, diaphoretic helped to sit down no syncope no loss of consciousness supine x 10 min then sat up received orange juice + felt better total 30 min (observation.
My husband had contact with someone who was positive. I got sick with what seemed like a head cold. When I found out that this other person was positive, I gave myself a test and it was negative. Got sicker and sicker. Two days later, woke up with achy joints, cough, sore throat, and terrible headache, and tested positive that day. Couldn't breathe very well and couldn't clear lungs. Was also very tired during this time. Called the doctor because I needed medicine for my breathing machine which I use rarely. It was on a weekend, and they filled the prescription and Monday I went to get more meds and an injection. In the process of recovery.
Pt reported feeling of lightheadedness, dizziness and had sweating a few minutes after receiving the injection.  Pt is breastfeeding just an FYI.
large reaction on arm, roughly the size of the palm of my hand, itchy red rash, skin warm to the touch, muscle swollen underneath
3/10/2021-Chills, Fever and disorientation (cognitive delay),, extreme brain fog 3/10/2021 -3/26/2021 Cognitive delay, brain fog-left keys in the front door, scissors in refrigerator, speech unfiltered, drafting memos at work with misspelled words
Patient was hospitalized 16 days after receiving COVID dose #3.  Patient passed away 56 days after receiving COVID dose #3.
Patient has red swollen splotches traveling slowly down her arm starting from the vaccination site where the pneumovax was given. It hurts to move her arm.
10 month male patient was maladministrated with Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-month-old male patient who received DTPa-IPV (Kinrix) (batch number D24G7, expiry date 4th June 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd March 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd March 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 10 month old patient received Kinrix, which led to inappropriate age at vaccine administration. No adverse event was performed. The reporter consented to follow up. This case has been linked with US2021072204, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021072204:same reporter
Narrative: Date of adverse event is unknown as fatigue and vomiting happened after patient left the facility. Patient reported adverse event Durning a telephone encounter 4 days later. Patient did no report any treatment mediations.
round patch that was itchy; red; warm; knot in that area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (knot in that area ), VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history.).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE INDURATION (knot in that area ). On 13-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm). At the time of the report, VACCINATION SITE INDURATION (knot in that area ), VACCINATION SITE PRURITUS (round patch that was itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE WARMTH (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment of the events were not reported.   Reporter did not allow further contact
Headache, fever, chills, lethargy, disorientation, loss of appetite, muscle soreness, pain at injection site.
Cellulitis treated with  ceftriaxone and Bactrim DS at urgent care center
Redness and swelling at injection site on left arm spreading distally from shoulder towards elbow over 24-72 hours with extreme sensitivity to touch and severe pain - within 24-48 hours fairly severe body (mostly back) ache, mild headache, malaise, fatigue, dizziness, and lightheadedness - low grade fever (100.1) at 48 hours - general body symptoms resolved between 48-72 hours - injection site remains mildly sensitive and red, but significantly improved at 120 hours.
Patient recieved Janssen vaccine from us on 4/7/21. She felt fine for 24 hours after but then on 4/8/21 she started to experience extreme joint pain and aches as well as generalized all over body swelling. This lasted for about 4 days. She is finally feeling better as of today 4/12/21. Patient states when she had covid she had the same all over body swelling.
Lightheaded with low heart rate 50-60 bpm for 60 minutes post vaccination. Even with hydration and food, took 60 min to clear. No syncopal episode. Blood pressure measured normal (120-140 systolic).
At the 15 minute mark post-vaccine, patient attempted to get up from chair and fell out. She was face down on stomach, clenching teeth, hands were slightly bowled up. She became conscious a under 2 minutes. She remained alert and responsive until the paramedics arrived. She did express failure to eat all day and feeling faint. We verbally obtained consent and verified the answers to the VARs.  Patient has no reactions/health conditions listed. She ensured the immunizer that she felt fine and was ready to be vaccinated. At the 15 minute mark, the immunizer checked in with her and again she said she was fine.
patient was here with mom on 11/6/21 sometime between 10am and 11am for her 1st dose of pfizer covid vaccine, within 1 minute of receiving the vaccine, mom stated that her daughter wasn't feeling well and shortly after her daughter had fainted onto the pharmacy counter. she also vomited right afterwards and felt better. she was given water and her outer jacket was removed due to feeling extremely hot. when she was alert and aware, was asked if she was very anxious/nervous and stated that she was. mom also stated normally she is anxious with vaccines but fainting was never a problem. mom and technician also called for EMS and when they arrived, they inspected her and took her via ambulance, was told shes fine and mom also followed up with pediatrician
Patient was inadvertently administered a Hepatitis A vaccine pediatric dose on 3/8/10 when presented for her well visit and other business. No adverse events reported to date. Event reported to CDC and reported to patient's mother on 3/8/10. Advised mother to contact office if any problems. Informed her. Information obtained no adverse events known.
Describes pain that never subsides. Changes in exact location to the muscles outside of the arm, shoulder, elbow and wrist. Activity does not aggravate. Medications and topical creams help with pain by about 50%. Denies redness or swelling.
This spontaneous report was received from a registered nurse via a company representative concerning a 4 months old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date approximately in March 2018 (reported as 2 months ago), the patient received a dose of the following vaccines: ROTATEQ, orally (frequency, strength, lot number and expiration date were not reported) for prophylaxis, PEDVAXHIB (frequency, strength, indication, lot number and expiration date were not reported) and PREVNAR (frequency, strength, indication, lot number and expiration date were not reported). On 02-MAY-2018, the patient received another dose of the vaccines listed above. On the same date, in the evening, the patient became flushed, and started crying, and had difficulty breathing. Furthermore, at night, the patient was taken to the Emergency Room. The patient was found to have a rectal temperature of 100 degrees Fahrenheit (°F), and it was sent home with TYLENOL. On the morning of 03-MAY-2018, the patient had episodes were breathing stopped, also had seizure like activity, and began to turn purple. Additionally, the patient vomited after breastfeeding. Then the patient was taken back to the emergency room. At the time of reporting, it was unknown the patient's outcome regarding the aforementioned events. The causality assessment of the events was unknown. Upon internal review, the event apnoea was determined to be medically significant.
Varicella vaccine given on 3/9/11 to an immune suppressed child who has underlying JRA per request of Rheumatologist. Phone call received on 3/31/11 from parent stating child awoke with blisters on neck and belly. Came in for office visit and admitted to hospital from doctor's office same day.
My ear has been injection ever since I got my shot. I got ringing in my right ear. Then, I went to A Fib in the beginning of January. I went to the ER. I was hospital for 3 days. They did EKG and Echo cardiogram, show that I was in A Fib. They also did blood work, normal result. I was referred to a cardiologist. They just did another EKG, normal results.
Patient received ZOSTAVAX shot  on 2/28/17. On 3/3/17 she reported that she had experienced redness, swelling and itching at injection site and towards elbow. She also developed a swollen lymph node.
puffy eyes- runny nose 2-3 hr p/vax;DPH & cold compress to eyes;saw MD-optometrist
1 of 3 pts immunized who exp a nodule @ the DTP inject site also had 1-2" area of induration & erythema; event occurred in pt w/in 48 hrs of vax;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 25Sep2021 at 15:00 as dose 3 (booster), single (Lot number: FC3184) at the age of 65 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa drugs" (unspecified if ongoing), notes: Known allergies: Sulfa drugs; "Known allergies: fluoroquinolones" (unspecified if ongoing), notes: Known allergies: fluoroquinolones. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset May2022, outcome "unknown", COVID-19 (medically significant) with onset May2022, outcome "recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Negative, notes: Home COVID test is now negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional Information: Anti-viral details: Product: COVID 19 Treatment (Pfizer), Treatment start date: 08May2022 and stop date: 012May2022, Indication is used for treatment of COVID-19. Other medication in 2weeks product: Alfuzosin, start date: 01May2022 and stop date: 08May2022. The patient had known allergies to Sulfa drugs and fluoroquinolones. Adverse event experienced on 20May2022 at 09:00 AM. The outcome of event not recovered. The patient did not receive treatment. Seem to have a rebound of COVID symptoms 7 days after completing Paxlovid treatment - fatigue and congestion. Home COVID test is now negative.  Follow-Up (24May2022): Follow-up attempts are completed. No further information is expected.
On 11/14/2021, that is when I started my period for over a week early, it has been going on since then, and it has not stopped. I consulted my doctor about it 11/23/2021. She said she has been hearing a lot of reports of women reporting similar symptoms after their vaccines. She said it should eventually work itself out.
I had four days after the vaccine I got serve migraine headaches. I've never had these in my life, these headaches lasts two weeks.  They would be non-stop unless I took Excedrin.  I went to see my PCP and he put me on stronger headache medication but they had no effect on me and went back to Excedrin. He observed me to make sure I was ok and had me take a Covid test to make sure I was ok , test was negative.
Allergic reaction in the form of hives on the underside of both arms, near the armpit.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Oct2022 as dose 4 (booster), single (Lot number: GH9697) at the age of 33 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: EL9266), in left arm, on 03Mar2021 as dose 2, single (Lot number: EN6205), in left arm and on 13Oct2021 as dose 3 (booster), single (Lot number: FF8841), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Ibuprofan for Known allergies: Ibuprofan; Asprin for Known allergies: Asprin. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid.
Fever of approximately 100.2 degrees.  I gave her the recommended dose of Tylenol for age and weight.
Patient received the third and final dose of the Hepatitis B adult vaccine series on 1/16/2014.  The patient called 1/24/2014 to report that she had experienced headache, dizziness, nausea without vomiting, and left arm and neck muscle soreness since waking up the morning of 1/17/2014.  Patient states she went to exercise class on 1/17/2014 and the symptoms "got worse for a few days and then started getting a little bit better."  She was unable to give exact days of exacerbation and decreasing of symptoms.  The patient reported she called her primary care physician and was told to take over the counter Bonine.  She states this lessened the symptoms but "made me loopy, so I only took one dose on Thursday evening" (1/23/2014)  As per the conversation on 1/24/2014, patient states she still has arm and neck muscle soreness with some headache, nausea and dizziness, but that it has decreased from the initial onset on 1/15/2014.  RN advised patient of listed side effects and adverse reactions of the Hepatitis B vaccine listed by the CDC, including headache and soreness at the injection site.  RN also advised patient of the possibility that symptoms could indicate other problems, some possibly serious, that are not vaccine related.  RN advised patient that she should seek medical attention for worsening or persisting symptoms.  RN requested patient keep HD apprised of any further symptoms or concerns, or if further medical care is rendered.  Patient verbalizes understanding, denies other questions or concerns.   RN called to follow up with patient on 1/28/2014 and left message.  Patient returned phone call 1/30/2014.  Patient states she "is feeling better every day," denies further complaints.
11/22/2018 Second hand notification from Employer. Patient admitted to hospital and doing spinal tap 10/22/18. Complained last week tingling of extremities and working up.
Initial report was retrieved via the scientific literature on 28 August 2012. From the published article: "INTRODUCTION: Following the 2009 influenza A/H1N1 (pH1N1) pandemic, both seasonal and pH1N1 viruses circulated during the 2010-2011 influenza season; influenza vaccine effectiveness (VE) may vary between live attenuated (LAIV) and trivalent inactivated (TIV) vaccines as well as by virus subtype. MATERIALS AND METHODS: Vaccine type and virus subtype-specific VE were determined for military active component personnel for the period of September 1, 2010 through April 30, 2011. Laboratory-confirmed influenza-related medical encounters were compared to matched individuals with a non-respiratory illness (healthy controls), and unmatched individuals who experienced a non-influenza respiratory illness (test-negative controls). Odds ratios (OR) and VE estimates were calculated overall, by vaccine type and influenza subtype. RESULTS: A total of 603 influenza cases were identified. Overall VE was relatively low and similar regardless of whether healthy controls (VE = 26%, 95% CI: -1 to 45) or test-negative controls (VE = 29%, 95% CI: -6 to 53) were used as comparison groups. Using test-negative controls, vaccine type-specific VE was found to be higher for TIV (53%, 95% CI: 25 to 71) than for LAIV (VE = -13%, 95% CI: -77 to 27). Influenza subtype-specific analyses revealed moderate protection against A/H3 (VE = 58%, 95% CI: 21 to 78), but not against A/H1 (VE = -38%, 95% CI: -211 to 39) or B (VE = 34%, 95% CI: -122 to 80). CONCLUSION: Overall, a low level of protection against clinically-apparent, laboratory-confirmed, influenza was found for the 2010-11 seasonal influenza vaccines. TIV immunization was associated with higher protection than LAIV, however, no protection against A/H1 was noted, despite inclusion of a pandemic influenza strain as a vaccine component for two consecutive years. Vaccine virus mismatch or lower immunogenicity may have contributed to these findings and deserve further examination in controlled studies. Continued assessment of VE in military personnel is essential in order to better inform vaccination policy decisions." Documents held by sender: none.
pt devel redness; warmth to touch; itching & swelling of face, neck, rt leg & fingers; erythematous papules spread to rt posterior aspect of leg; tx: hydroxyzine hydrochloride Atarax;
Increased heart rate / tachycardia, vasovagal syncope, extreme fatigue, inability to exercise (was an avid runner before), vertigo / imbalance, nausea.
Began having high pitched crying at 8PM could not be consoled. Seen by FMD dx adverse rxn given tylenol; crying lasted x  24hrs.
H1N1 given on November 4, 2009. Symptoms started on November 8, 2009. Severe pain on left side of my head shocking down both arms and legs. As of March 15, 2010 I am still under the doctor care.
Pt ran a fever 20 hours after Tdap injection. Fever lasted about 12 hours. Injection site redness, heat, swelling, "knotted muscle". Sx 5 days. Resolved on it's own.
got vaccinated in Feb and until now haven't suffered from any headaches or earaches of any kind since then; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (got vaccinated in Feb and until now haven't suffered from any headaches or earaches of any kind since then) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Headache, Earache and Sinus disorder NOS (Sinus) since an unknown date.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (got vaccinated in Feb and until now haven't suffered from any headaches or earaches of any kind since then). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (got vaccinated in Feb and until now haven't suffered from any headaches or earaches of any kind since then) outcome was unknown. Headaches      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included unknown pain pills for the treatment of headache and earache, nose sprays for the treatment of sinus.  On a social media platform the patient stated that after vaccination the patient's headaches, earaches and pain pills were "put away". No other treatment information was provided by the reporter.
Pt received covid vaccine by MA and had her sit in hall for monitoring. Before the 10 mins MA asked how she was doing and patient stated ?she had a bad taste in her mouth? MA had her wait another 10 mins and checked on her.  When she went to check on her the second time patient stated she had tingling feeling in her throat and felt nauseated. MA informed Dr. he instructed her to give the patient 10ml of liquid Benadryl and monitored her. MA stayed with the patient to monitor closely then Dr. went to go examine her. Patients tongue and lips were swollen at this time. Dr. had her wait for the Benadryl to start working and rechecked her with Dr. and then order a dose of methylprednisolone 80mg. Patient waited about an hour and showed improvement. Dr. released her home without emergency services.
extreme exhaustion every evening for a week, considerable exhaustion noticeable after that as well; heart flutters on 3 different occasions; brain lapses (extreme forgetfulness continuing for weeks)